Progyny (PGNY) Receivables (2018 - 2026)

Progyny (PGNY) has 9 years of Receivables data on file, last reported at $299.0 million in Q1 2026.

• Quarterly Receivables fell 16.51% year-over-year to $299.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $299.0 million (down 16.51% YoY) and the FY2025 annual result came in at $254.2 million, down 9.97% from the prior year.
• Receivables improved to $299.0 million in Q1 2026 per PGNY's latest filing, from $254.2 million in the prior quarter.
• Across five years, Receivables topped out at $370.3 million in Q2 2024 and bottomed at $229.4 million in Q1 2022.
• The 5-year median for Receivables is $310.5 million (2023), against an average of $309.7 million.
• The widest annual swing landed in 2022, when Receivables surged 102.36%; it then retreated 16.51% in 2026.
• Tracing PGNY's Receivables over 5 years: stood at $283.0 million in 2022, then increased by 1.41% to $287.0 million in 2023, then slipped by 1.62% to $282.3 million in 2024, then decreased by 9.97% to $254.2 million in 2025, then advanced by 17.64% to $299.0 million in 2026.
• Per Business Quant, the three latest PGNY Receivables figures stand at $299.0 million (Q1 2026), $254.2 million (Q4 2025), and $296.8 million (Q3 2025).

Peer Comparison